#USA #Portland #RxAnte #Primus Capital #Mosaic Pharmacy

RxAnte Secures Strategic Investment to Fuel Growth

RxAnte, a leader in analytics and technology for pharmacy care management, has recently disclosed a substantial growth investment from Primus Capital. This strategic partnership aims to boost RxAnte’s efforts in scaling its innovative value-based pharmacy solutions, ultimately enhancing clinical services provided to health plans and their members who require advanced drug therapy management.

Founded on the foundation of utilizing healthcare data and advanced analytics, RxAnte has historically focused on assessing the risks associated with unsafe medication use, managing programs that enhance prescribing and adherence, and measuring outcomes for vulnerable populations. It’s noteworthy that by 2026, the company aims to manage over 34 million lives through partnerships with leading regional and national health plans.

The timing of this investment, which comes as RxAnte’s technology-enabled pharmacy care management subsidiary, Mosaic Pharmacy Service, is experiencing rapid growth, is pivotal. Mosaic provides tailored, data-driven pharmacy care specifically for medically complex and vulnerable populations. Some peer-reviewed outcome studies, in collaboration with UPMC Health Plan, have validated Mosaic’s effectiveness in improving member health, reducing hospitalizations, and lowering medical costs while also enhancing quality scores.

Josh Benner, Co-Founder and CEO of RxAnte, emphasized the significance of this partnership, stating, "Our collaboration with Primus Capital is a turning point for RxAnte. With the rising costs in medications and the ongoing focus on quality measurements, the need for more individualized and coordinated pharmacy care is paramount. Our long-standing partnership with UPMC has been instrumental in creating a truly unique and value-driven model of pharmacy care tailored for medically complex and socially vulnerable patients."

Brent Burns, Executive Vice President of UPMC Enterprises, echoing Benner’s sentiments, remarked, "Primus shares our vision of transforming pharmacy care management through data. This partnership will enable us to scale our RxAnte solutions and bring them to an even broader patient base."

Primus Capital, a private equity firm with an established record in the healthcare technology and services industry, recognized RxAnte as a leader in the pharmacy care management space. Phil Molner, Managing Partner at Primus Capital, expressed enthusiasm about the partnership, stating, "We are thrilled to team up with the RxAnte team. They have developed a groundbreaking, data-driven platform that addresses one of the most enduring challenges in healthcare. We’re eager to support their ongoing innovation and expansion as they redefine pharmacy's role in improving health outcomes."

About RxAnte

RxAnte is a health technology and services organization committed to helping individuals manage complex medication regimens to lead longer and healthier lives. By leveraging analytics, software, and the capabilities of their subsidiary, Mosaic Pharmacy Service, RxAnte delivers critical insights and clinical services to help improve medication use on a population level.

For more information about RxAnte, visit www.rxante.com.

About Primus Capital

Primus Capital is a private equity firm focused on growth investments in leading enterprises across healthcare, software, and technology-driven services sectors. Their approach involves collaboration with management teams to drive growth through operational enhancements, strategic oversight, and necessary capital for expansion.

Find out more about Primus Capital by visiting www.primuscapital.com.

In summary, this partnership between RxAnte and Primus Capital represents a significant step forward in improving pharmacy care management, ensuring that patients receive tailored, effective, and efficient medication management.